Table 2.
Univariate and multivariate analysis of overall survival in OS patients
| Clinicopathological features | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | |
| Gender | 0.936 | 0.641-2.513 | 0.482 | |||
| Male vs. Female | ||||||
| Age (years) | 1.214 | 0.753-2.906 | 0.376 | |||
| ≥25 vs. <25 | ||||||
| Tumor size | 2.427 | 0.815-5.186 | 0.043 | |||
| ≥8 cm vs. <8 cm | ||||||
| Anatomic location | 0.864 | 0.572-2.356 | 0.294 | |||
| Elsewhere vs. Tibia/femur | ||||||
| Clinical stage | 3.784 | 2.417-7.768 | 0.002 | 3.271 | 2.293-6.579 | 0.005 |
| IIB/III vs. IIA | ||||||
| Distant metastasis | 4.726 | 1.943-9.675 | 0.004 | 4.375 | 1.801-8.739 | 0.009 |
| Presence vs. Absence | ||||||
| HOTTIP | 3.018 | 1.487-7.241 | <0.001 | 2.887 | 1.367-7.061 | 0.007 |
| High vs. Low | ||||||